Danny L. Dearen, See Remarks at Axonics, Inc. (AXNX), sold 200,000 shares at $62.15 ($11.8M) on 2021-04-21, disclosed to the SEC on 2021-04-23.
Open-market sale of $11.8M AXNX by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.14 | 73,231 | $4.3M | 36.1% |
| 2 | $58.14 | 73,231 | $4.3M | 36.1% |
| 3 | $58.61 | 1,769 | $104K | 0.9% |
| 4 | $58.61 | 1,769 | $104K | 0.9% |
| 5 | $60.30 | 2,572 | $155K | 1.3% |
| 6 | $60.30 | 2,572 |
| $155K |
| 1.3% |
| 7 | $61.58 | 14,382 | $886K | 7.5% |
| 8 | $61.58 | 14,382 | $886K | 7.5% |
| 9 | $62.15 | 8,046 | $500K | 4.2% |
| 10 | $62.15 | 8,046 | $500K | 4.2% |
| Total | $59.02 avg | 200,000 | $11.8M | 100% |
| Filing → |
| AXNX | SELL | 2023-04-25 | $2.4M | — | Filing → |
| AXNX | SELL | 2023-04-24 | $240K | — | Filing → |
| AXNX | SELL | 2023-04-04 | $1.7M | — | Filing → |